Skip to content
Fund Overview
  • Listed
  • Biotechnology — Full Life Cycle

RTW Biotech Opportunities Ltd. is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. The Fund’s approach is driven by applying deep scientific expertise with a long-term investment horizon.

RTW Biotech Opportunities Ltd (“RTW”) appointed Cadarn Capital in May 2023 to provide distribution and investor relations services.

RTW Biotech Opportunities Ltd. is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. The Fund’s approach is driven by applying deep scientific expertise with a long-term investment horizon.

RTW believe the companies best positioned to overcome these near-term challenges will be those who have chosen to focus on therapies for severe diseases with limited options and that also have meaningful commercial potential.  

Play video
11 September 2025

Latest Report

28 February 2026

Latest Factsheet

11 September 2025

Latest Presentation

Fund Documents

Catch up on latest Cadarn Fund Partner RNS

Latest Press
Investor Portal

Exclusive access for professional investors

The Investor Portal provides professional investors with exclusive access to upcoming Cadarn events, detailed fund portfolio insights and associated fund materials. A dedicated information hub that offers an insight into our fund partners’ respective investment approaches, market insights and fund news.

Sign up

Cadarn Capital Ltd (FRN: 998015) is an appointed representative of Thornbridge Investment Management LLP (FRN: 713859) which is authorised and regulated by the Financial Conduct Authority